CFO Sells $1.8 Million in Stock After Option Exercise Amidst Executive Selling Trend
Summary
Ambiq Micro's CFO sold $1.8 million in common stock following an option exercise, contributing to a significant trend of executive selling that includes the CEO and President/COO, with sales occurring near the stock's 52-week high.
Key Events
-
CFO Sells $1.8 Million in Stock
Jeffrey G. Winzeler, Chief Financial Officer, sold 26,000 shares of common stock for $1,817,412 on the open market on May 14, 2026.
-
Sale Follows Option Exercise
The open market sale occurred after the CFO exercised options to acquire 31,952 shares for $536,794 between May 14-15, 2026.
-
Part of Broader Executive Selling Trend
This transaction is part of a significant distribution signal, with over $8.8 million in net insider sales by active insiders in the last 90 days. This includes concurrent sales by the CEO ($4.2M) and President/COO ($3.9M) on the same day as this filing.
-
Stock Trading Near 52-Week High
The sales by the CFO and other executives occurred while Ambiq Micro's stock is trading near its 52-week high of $73.72, potentially indicating profit-taking.
Analysis
Ambiq Micro's Chief Financial Officer, Jeffrey G. Winzeler, sold $1.8 million worth of common stock on the open market after exercising options. This transaction is significant not only due to the amount and the executive's role but also because it is part of a broader pattern of substantial insider selling at the company. Other key executives, including the CEO and President/COO, also reported large sales on the same day, bringing the total executive sales to nearly $10 million. The sales occurred while the stock is trading near its 52-week high, suggesting executives may be locking in gains. This concentrated selling by multiple top executives could be viewed negatively by investors, despite the company's recent strong financial results.
At the time of this filing, AMBQ was trading at $71.34 on NYSE in the Manufacturing sector, with a market capitalization of approximately $1.5B. The 52-week trading range was $22.12 to $73.72. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.